(Q60637647)

English

Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

scholarly article published in Nature Medicine

In more languages
default for all languages
No label defined

No description defined

Statements

0 references
0 references
Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (English)
0 references
0 references
0 references
0 references
Sandeep T Patil
0 references
Lu Zhang
0 references
Ferenc Martenyi
0 references
Stephen L Lowe
0 references
Kimberley A Jackson
0 references
Alla S Avedisova
0 references
Leonid M Bardenstein
0 references
Issak Y Gurovich
0 references
Sergey N Mosolov
0 references
Nikolai G Neznanov
0 references
Alexander M Reznik
0 references
Vladimir A Tochilov
0 references
Bryan G Johnson
0 references
James A Monn
0 references
Darryle D Schoepp
0 references
October 2007
0 references
13
0 references
10
0 references
1264-1264
0 references

Identifiers

0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit